These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2743707)

  • 1. Pharmacokinetic interaction between intravenous phenytoin and amiodarone in healthy volunteers.
    Nolan PE; Marcus FI; Hoyer GL; Bliss M; Gear K
    Clin Pharmacol Ther; 1989 Jul; 46(1):43-50. PubMed ID: 2743707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state interaction between amiodarone and phenytoin in normal subjects.
    Nolan PE; Erstad BL; Hoyer GL; Bliss M; Gear K; Marcus FI
    Am J Cardiol; 1990 May; 65(18):1252-7. PubMed ID: 2337037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of phenytoin on the clinical pharmacokinetics of amiodarone.
    Nolan PE; Marcus FI; Karol MD; Hoyer GL; Gear K
    J Clin Pharmacol; 1990 Dec; 30(12):1112-9. PubMed ID: 2273084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amiodarone on oral and intravenous digoxin kinetics in healthy subjects.
    Santostasi G; Fantin M; Maragno I; Gaion RM; Basadonna O; Dalla-Volta S
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):385-90. PubMed ID: 2438499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin.
    Milne RW; Coulthard K; Nation RL; Penna AC; Roberts G; Sansom LN
    Br J Clin Pharmacol; 1988 Sep; 26(3):330-3. PubMed ID: 3179171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin: pharmacokinetics and bioavailability.
    Gugler R; Manion CV; Azarnoff DL
    Clin Pharmacol Ther; 1976 Feb; 19(2):135-42. PubMed ID: 1261151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
    Fruncillo RJ; Kozin SH; DiGregorio GJ
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effect of valproic acid on the pharmacokinetics of phenytoin.
    Lai ML; Huang JD
    Biopharm Drug Dispos; 1993 May; 14(4):365-70. PubMed ID: 8499586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluconazole on the disposition of phenytoin.
    Blum RA; Wilton JH; Hilligoss DM; Gardner MJ; Henry EB; Harrison NJ; Schentag JJ
    Clin Pharmacol Ther; 1991 Apr; 49(4):420-5. PubMed ID: 2015731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of activated charcoal on phenytoin pharmacokinetics.
    Rowden AM; Spoor JE; Bertino JS
    Ann Emerg Med; 1990 Oct; 19(10):1144-7. PubMed ID: 2221521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of phenytoin elimination by multiple-dose activated charcoal.
    Mauro LS; Mauro VF; Brown DL; Somani P
    Ann Emerg Med; 1987 Oct; 16(10):1132-5. PubMed ID: 3662159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pharmacokinetic interaction between bromfenac and phenytoin in healthy males.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Clin Pharmacol; 1997 Feb; 37(2):160-8. PubMed ID: 9055143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide.
    Windle J; Prystowsky EN; Miles WM; Heger JJ
    Clin Pharmacol Ther; 1987 Jun; 41(6):603-10. PubMed ID: 3581646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of urinary excretion of p-hydroxyphenytoin in healthy subjects given phenytoin.
    Dickinson RG; Hooper WD; Patterson M; Eadie MJ; Maguire B
    Ther Drug Monit; 1985; 7(3):283-9. PubMed ID: 4049465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between amiodarone and lidocaine.
    Ha HR; Candinas R; Stieger B; Meyer UA; Follath F
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):533-9. PubMed ID: 8891878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction of single doses of quinine and carbamazepine, phenobarbitone and phenytoin in healthy volunteers.
    Amabeoku GJ; Chikuni O; Akino C; Mutetwa S
    East Afr Med J; 1993 Feb; 70(2):90-3. PubMed ID: 8513749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers.
    Fischer TL; Pieper JA; Graff DW; Rodgers JE; Fischer JD; Parnell KJ; Goldstein JA; Greenwood R; Patterson JH
    Clin Pharmacol Ther; 2002 Sep; 72(3):238-46. PubMed ID: 12235444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerance and pharmacokinetics of intravenous doses of the phosphate ester of 3-hydroxymethyl-5,5-diphenylhydantoin: a new prodrug of phenytoin.
    Gerber N; Mays DC; Donn KH; Laddu A; Guthrie RM; Turlapaty P; Quon CY; Rivenburg WK
    J Clin Pharmacol; 1988 Nov; 28(11):1023-32. PubMed ID: 3243914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.